Merck & Co., Inc. (MRK) stock analysis
In our weekly check, Merck & Co., Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 5.
About Merck & Co., Inc.
Merck & Co., Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as MRK.
What our checks show for MRK
Red flags
- The net margin fell by 23.1 points over 5 years, to 3.6%: the company keeps less of each sale as profit.
- The net margin is only 3.6%: little room if costs rise.
- The dividend takes 341% of profit: little cushion if profit falls.
- The stock has fallen as much as 65% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 5.4 years.
Warning signs
- Net debt is 3.7x a year of EBITDA (debt/equity 1.2). That limits room in a downturn and raises refinancing risk.
- Analysts expect only about 4% a year of growth in revenue.
- Revenue grew only 4.3% a year over the last 3 years.
- Earnings per share fell 44.3% a year over the last 3 years.
- Net profit fell 44.7% a year over the last 3 years.
- Return on capital (ROCE) is only 8.8%.
Strengths
- The gross margin is 74.7% and has risen by 2.6 points: pricing power is holding.
- Operating cash flow is 7.62x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 178% a year over the next years.
- Analysts expect the net margin to improve by 29.6 points from today's 3.6%.
- Free cash flow is 21.9% of revenue: cash for dividends, buybacks or growth.
- A large company: market value $364 billion.
Next earnings report: 2027-02-02
Similar companies
NVS · AZN · ABBV · AMGN · GILD · JNJ
Questions
What grade does Merck & Co., Inc. (MRK) have?
In our weekly check, Merck & Co., Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of MRK stock?
This week's biggest flags for Merck & Co., Inc.: Margins falling, Thin margins, Dividend stretched. In total 11 of 25 checks show a warning or a red flag.
What does Merck & Co., Inc. do?
Merck & Co., Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as MRK.
When does Merck & Co., Inc. report earnings next?
The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis